| Literature DB >> 32804093 |
Robin van den Kieboom1,2, Liselore Snaphaan1,2, Ruth Mark3, Inge Bongers1,2.
Abstract
BACKGROUND: Caring for patients with dementia at home is often a long-term process, in which the independence of the patient declines, and more responsibility and supervision time is required from the informal caregiver.Entities:
Keywords: Caregiver burden; dementia; informal caregiver; longitudinal study; progression; systematic review
Year: 2020 PMID: 32804093 PMCID: PMC7683084 DOI: 10.3233/JAD-200647
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472
Fig. 1Search and analysis strategy.
Summary of included studies
| Reference | Sample size baseline at (informal caregivers) | Dementia type | Follow-up (months) | Number of assessments | Outcome measure | Caregiver burden measure |
| Kajiwara et al., 2018 [ | 41 | Dementia | 12 | 3 | Burden | J-ZBI |
| Borsje et al., 2016 [ | 117 | Dementia | 18 | 3 | Psychological distress | SCQ, CES-D, GHQ-12 |
| Kawaharada et al., 2019 [ | 117 | AD | 36 | 2 | Burden | ZBI |
| Raccichini et al., 2015 [ | 153 | AD | 6 | 2 | Burden | CBI |
| Svendsboe et al., 2018 [ | 162 | AD and DLB | 36 | 4 | Psychological distress | RSS |
| Hallikainen et al., 2017 [ | 226 | AD | 36 | 4 | Psychological distress | GHQ-12 |
| Conde-Sala et al., 2014 [ | 330 | AD | 36 | 4 | Burden | ZBI |
| Viñas-Diez et al., 2017 [ | 275 | AD | 24 | 3 | Burden | ZBI |
| Brodaty et al., 2014 [ | 732 | Dementia | 12 | 3 | Burden | ZBI |
| Reed et al., 2019 [ | 969 | AD | 36 | 7 | Burden | ZBI |
| Bleijlevens et al. 2014 [ | 2014 | Dementia | 3 | 2 | Burden | ZBI, CRA |
AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; J-ZBI, Japanese version of the Zarit Burden Inventory; SCQ, Sense of Competence Questionnaire; CES-D, Center for Epidemiological Studies Depression Scale; GHQ-12, General Health Questionnaire -12; ZBI, Zarit Burden Inventory; CBI, Caregiver Burden Inventory; RSS, Relative’s Stress Scale; CRA, Caregiver Reaction Assessment.
Evaluation of individual study quality with The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses
| [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | [ | ||
| Selection | 1) Representativeness of the exposed cohort: | a | a | a | a | a | a | a | a | a | a | a |
| a) truly representative of the average patient with dementia in the community*; b) somewhat representative of the average patient with dementia in the community*; c) selected group of users, e.g., nurses, volunteers; d) no description of the derivation of the cohort | ||||||||||||
| 2) Selection of the non-exposed cohort: | a | a | a | a | a | a | a | a | a | a | a | |
| a) drawn from the same community as the exposed cohort*; b) drawn from a different source; c) no description of the derivation of the non-exposed cohort | ||||||||||||
| 3) Ascertainment of exposure: | c | c | b | c | c | c | b | c | c | c | b | |
| a) secure record (e.g. surgical records)*; b) structured interview*; c) written self-report; d) no description | ||||||||||||
| 4) Demonstration that outcome of interest was not present at start of study: | a | a | a | a | a | a | a | a | a | a | a | |
| a) yes*; b) no | ||||||||||||
| Comparability | 1) Comparability of cohorts on the basis of the design or analysis: | |||||||||||
| a) study controls for patients or caregiver factors | X | X | X | X | X | X | X | X | X | X | X | |
| b) study controls for context factors | X | X | X | X | X | X | X | X | X | |||
| Outcome | 1) Assessment of outcome: | c | c | c | c | c | c | c | c | c | c | c |
| a) independent blind assessment*; b) record linkage; c) self-report; d) no description | ||||||||||||
| 2) Was follow-up long enough for outcomes to occur > 6 months: | a | a | a | b | a | a | a | a | a | a | b | |
| a) yes*; b) no | ||||||||||||
| 3) Adequacy of follow up of cohorts: | b | b | a | b | c | b | b | b | c | c | a | |
| a) complete follow up - all subjects accounted for*; b) subjects lost to follow up unlikely to introduce bias - less than 50 % lost or description of those lost suggested no difference from those followed*; c) follow up rate < 50% and no description of those lost; d) no statement | ||||||||||||
| Total number of stars | 7 | 7 | 8 | 7 | 5 | 6 | 8 | 7 | 6 | 6 | 8 | |
| Quality rating according to guideline* | Good | Good | Good | Good | Fair | Fair | Good | Good | Fair | Fair | Good |
*Thresholds for converting the NOS rating to Agency for Healthcare Research and Quality (AHRQ) standards (good, fair, and poor): Good quality: 3 or 4 stars in Selection domain AND 1 or 2 stars in Comparability domain AND 2 or 3 stars in Outcome domain. Fair quality: 2 stars in Selection domain AND 1 or 2 stars in Comparability domain AND 2 or 3 stars in Outcome domain. Poor quality: 0 or 1 star in Selection domain OR 0 stars in Comparability domain OR 0 or 1 stars in Outcome domain. Note: A study can be awarded a maximum of one star for each numbered item within the Selection and Outcome categories. A maximum of two stars can be given for Comparability.
The different patient, caregiver, and context characteristics assessed in the included studies
| Risk factor | Study references |
| Patient characteristics | |
| Behavioral and neuropsychiatric symptoms | Kajiwara et al. [ |
| Functional status | Kawaharada et al. [ |
| Cognitive status | Kajiwara et al. [ |
| Caregiver characteristics | |
| Age | Borsje et al. [ |
| Gender | Borsje et al. [ |
| Physical and mental health | Conde-Sala et al. [ |
| Context characteristics | |
| Cohabitation | Raccichini et al. [ |
| Kinship | Conde-Sala et al. [ |
| Sole caregiver | Conde-Sala et al. [ |